NurExone Biologic Inc.
BiotechnologyBiopharmaceuticals, Neurological Treatments
About
NurExone Biologic Inc. is a publicly traded biopharmaceutical company based in Canada, specializing in the development of innovative treatments for neurological injuries, particularly focusing on spinal cord injuries. Their research and products aim to address the significant need for effective recovery solutions for patients suffering from acute spinal cord trauma.
Company Values
NurExone's unique focus on non-invasive exosome-based therapies, like ExoPTEN, sets it apart from traditional treatment methodologies.